| dc.contributor.author | Tunc, H. M. | |
| dc.contributor.author | VAROL, U. | |
| dc.contributor.author | Sen, F. | |
| dc.contributor.author | YILDIZ, I. | |
| dc.contributor.author | Kilic, L. | |
| dc.contributor.author | Kilicaslan, Işın | |
| dc.contributor.author | Ekenel, M. | |
| dc.contributor.author | Darendeliler, E. | |
| dc.contributor.author | Bavbek, S. | |
| dc.contributor.author | Basaran, M. | |
| dc.contributor.author | Ordu, C. | |
| dc.date.accessioned | 2021-03-05T16:31:45Z | |
| dc.date.available | 2021-03-05T16:31:45Z | |
| dc.date.issued | 2013 | |
| dc.identifier.citation | YILDIZ I., Sen F., Kilic L., Ekenel M., Ordu C., Kilicaslan I., Darendeliler E., Tunc H. M. , VAROL U., Bavbek S., et al., "Prognostic factors associated with the response to sunitinib in patients with metastatic renal cell carcinoma", CURRENT ONCOLOGY, cilt.20, 2013 | |
| dc.identifier.issn | 1198-0052 | |
| dc.identifier.other | av_c117d591-295c-45a1-93a8-ef220e6b5301 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/128159 | |
| dc.identifier.uri | https://doi.org/10.3747/co.20.1596 | |
| dc.description.abstract | Objective | |
| dc.language.iso | eng | |
| dc.subject | Onkoloji | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Klinik Tıp | |
| dc.subject | ONKOLOJİ | |
| dc.title | Prognostic factors associated with the response to sunitinib in patients with metastatic renal cell carcinoma | |
| dc.type | Makale | |
| dc.relation.journal | CURRENT ONCOLOGY | |
| dc.contributor.department | Ankara Training & Research Hospital , , | |
| dc.identifier.volume | 20 | |
| dc.identifier.issue | 6 | |
| dc.contributor.firstauthorID | 20398 | |
